Analystreport

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $42.00 price target on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com